Global /South Korea /Healthcare /Drug Manufacturers - General /032300

KOREA PHARMA Co., Ltd.

032300

• KRX: 032300 • Delayed

11,850KRW 0.9%

7.85 USD

As of 18 June 2026, KOREA PHARMA Co., Ltd. has a market cap of $84.73M USD, ranking #26699 globally and #1348 in South Korea. It ranks #2395 in the Healthcare sector, and #864 in the Drug Manufacturers - General industry.

Global Rank

26699

Country Rank

1348

Sector Rank

2395

Industry Rank

864

Key Stats

Market Cap

$84.73MUSD

129.24B KRW

Enterprise Value

$93.18MUSD

140.65B KRW

Revenue (TTM)

$57.43MUSD

87.6B KRW

EBITDA (TTM)

$1.51MUSD

2.28B KRW

Net Income (TTM)

-$1.73MUSD

-2.64B KRW

EBITDA Margin

2.6%

Profit Margin

-3%

PS Ratio

1.5

PB Ratio

1.9

EV/EBITDA

70.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Eun-Hee Park open_in_new

Employees

134

Founded

1974

Website

koreapharma.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.9%	-0.3%	0.9%	-8.2%	-12%	-8.8%	-18%	-41%	-78%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	032300 (주)한국파마는 우수의 Ordinary Shares ISIN: KR7032300006 Shares Out.: Shares Outstanding: 10.907M¹ Shares Float: 3.916M² TV: TradingView: KRX: 032300 SA: Stock Analysis: KRX: 032300 YF: Yahoo Finance: 032300.KS GF: Google Finance: KRX: 032300 BA: Barron's: 032300 MS: Morningstar: XKRX: 032300	11,850 KRW	TV: TradingView: KRX: 032300 SA: Stock Analysis: KRX: 032300 YF: Yahoo Finance: 032300.KS GF: Google Finance: KRX: 032300 BA: Barron's: 032300 MS: Morningstar: XKRX: 032300

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About KOREA PHARMA Co., Ltd.

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.12B 13.91T KRW 11K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.75B 10.3T KRW 8K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.23B 7.97T KRW 6K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.95B 7.55T KRW 6K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.54B 6.92T KRW 5K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.43B 6.76T KRW 5K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 899K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 646K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 426K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 381K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 342K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 326K%	20.5	Switzerland

chevron_leftBack